Lineage Cell Therapeutics (LCTX) Shares Outstanding (2010 - 2026)
Lineage Cell Therapeutics (LCTX) shares outstanding from Dec 31, 2010 to Mar 31, 2026. The current Lineage Cell Therapeutics (LCTX) shares outstanding is 249.30M. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Shares Outstanding
Lineage Cell Therapeutics (LCTX) Shares Outstanding CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +8.03% |
| 3 Years TTM | +6.97% |
| 5 Years TTM | +6.23% |
| 10 Years TTM | +8.02% |
| All Time TTM | +11.67% |
Annual Shares Outstanding change of Lineage Cell Therapeutics (LCTX)
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 | 249.30M | +2.54% |
| 2025 | 243.12M | +10.30% |
| 2024 | 220.42M | +10.20% |
| 2023 | 200.01M | +2.88% |
| 2022 | 194.42M | +0.36% |
| 2021 | 193.71M | +10.70% |
| 2020 | 174.99M | +2.20% |
| 2019 | 171.23M | +17.83% |
| 2018 | 145.32M | +0.21% |
| 2017 | 145.01M | +13.87% |
| 2016 | 127.34M | +13.66% |
| 2015 | 112.03M | +6.63% |
| 2014 | 105.07M | +37.93% |
| 2013 | 76.17M | +14.85% |
| 2012 | 66.33M | +0.71% |
| 2011 | 65.86M | +2.63% |
| 2010 | 64.17M | N/A |